Michigan Institution of Women's Health PC

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Michigan Institution of Women's Health PC sits in the upper half of US sponsors by registered trial count (#4,885 of 15,742 sponsors by registered trial count).

2 total trials none currently recruiting 2 completed upper half by trial count

Michigan Institution of Women's Health PC: 2 sponsored US clinical trials, none currently recruiting.

Michigan Institution of Women's Health PC sponsors 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 2 completed. The most-studied condition in this pipeline is Genitourinary Syndrome of Menopause, with 1 trials.

Mid-pack sponsor footprint

Michigan Institution of Women's Health PC is in the upper half of sponsors by trial count (#4,885 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

How the Michigan Institution of Women's Health PC archive is shaped

2 indexed studies, none listed as recruiting (0% open); 2 completed (100%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Genitourinary Syndrome of Menopause (1 trial), 2 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Michigan Institution of Women's Health PC: archived-pipeline peers nationwide

Peers matched on 2 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Michigan Institution of Women's Health PC sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%20%40%60% Total trials Recruiting share Michigan Institution of Women's Health PC1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO Health10xBio22nd Century Group23andMe3-C Institute for Social Development
Michigan Institution of Women's Health PC sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Michigan Institution of Women's Health PC sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 2 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Michigan Institution of Women's Health PC page

2 registered trials is a research-attention snapshot, not an endorsement of Michigan Institution of Women's Health PC or any single study.

  • None of Michigan Institution of Women's Health PC's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Genitourinary Syndrome of Menopause is the condition Michigan Institution of Women's Health PC studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Genitourinary Syndrome of Menopause trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Michigan Institution of Women's Health PC pipeline card: 2 registered trials from official public datasets.Report a data error.